Commerzbank AG (FRA:CBK)
Germany · Delayed Price · Currency is EUR 34.38
+1.21 (3.65%)
Last updated: Aug 8, 2025
Verve Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 2,688 | 2,677 | 2,224 | 1,435 | 430 | -2,870 | Upgrade |
Depreciation & Amortization | 548 | 459 | 437 | 515 | 525 | 568 | Upgrade |
Other Amortization | 400 | 400 | 387 | 409 | 427 | 457 | Upgrade |
Gain (Loss) on Sale of Assets | 12 | 12 | 11 | 36 | 4 | 1 | Upgrade |
Total Asset Writedown | - | - | 25 | 11 | 218 | 67 | Upgrade |
Change in Trading Asset Securities | -41,676 | -41,676 | -23,587 | 6,683 | -4,380 | -12,165 | Upgrade |
Change in Other Net Operating Assets | 14,551 | 14,551 | 38,724 | 22,200 | -30,994 | 44,691 | Upgrade |
Other Operating Activities | -6,408 | 3,262 | 2,061 | -5,430 | 9,509 | 2,927 | Upgrade |
Operating Cash Flow | -29,885 | -20,315 | 20,282 | 25,859 | -24,261 | 33,676 | Upgrade |
Operating Cash Flow Growth | - | - | -21.57% | - | - | - | Upgrade |
Capital Expenditures | -1,146 | -1,146 | -998 | -675 | -973 | -898 | Upgrade |
Sale of Property, Plant and Equipment | 35 | 35 | 57 | 55 | 278 | 112 | Upgrade |
Cash Acquisitions | -262 | -262 | -2 | -62 | -24 | -433 | Upgrade |
Divestitures | 59 | 59 | 22 | -30 | -85 | -2 | Upgrade |
Other Investing Activities | 367 | 1 | 1 | -1 | - | - | Upgrade |
Investing Cash Flow | -947 | -1,313 | -920 | -713 | -804 | -1,221 | Upgrade |
Long-Term Debt Issued | - | 1,245 | - | 477 | - | 818 | Upgrade |
Long-Term Debt Repaid | - | -292 | -722 | -299 | -1,706 | -345 | Upgrade |
Net Debt Issued (Repaid) | 953 | 953 | -722 | 178 | -1,706 | 473 | Upgrade |
Issuance of Common Stock | 1,310 | 1,310 | - | - | 496 | 1,734 | Upgrade |
Repurchase of Common Stock | -1,072 | -1,072 | -122 | - | - | - | Upgrade |
Common Dividends Paid | -946 | -627 | -444 | - | - | - | Upgrade |
Other Financing Activities | -402 | 1 | -1 | - | -1 | 1 | Upgrade |
Financing Cash Flow | -157 | 565 | -1,289 | 178 | -1,211 | 2,208 | Upgrade |
Foreign Exchange Rate Adjustments | -640 | 939 | -180 | 402 | 179 | -223 | Upgrade |
Net Cash Flow | -31,628 | -20,124 | 17,893 | 25,726 | -26,097 | 34,440 | Upgrade |
Free Cash Flow | -31,031 | -21,461 | 19,284 | 25,184 | -25,234 | 32,778 | Upgrade |
Free Cash Flow Growth | - | - | -23.43% | - | - | - | Upgrade |
Free Cash Flow Margin | -279.91% | -205.90% | 194.49% | 290.54% | -315.31% | 499.59% | Upgrade |
Free Cash Flow Per Share | -26.83 | -18.07 | 15.48 | 20.11 | -20.15 | 26.17 | Upgrade |
Cash Interest Paid | 12,832 | 12,832 | 8,802 | 3,739 | 2,477 | 2,810 | Upgrade |
Cash Income Tax Paid | 544 | 544 | 673 | 233 | 328 | -23 | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.